iScience · 2023 · 26 citations · 38 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyGut MicrobiotaOncolytic Virus ImmunotherapyOncolytic Virus TherapyTumor Immune MicroenvironmentCross-reactive ImmunityGut Microbiota DysbiosisHost-microbiome Interactions In CancerImmunogenic Cell Death InductionMelanoma ProgressionOncolytic Viral TherapyOncolytic Virus-induced Immunogenic Cell DeathSyngeneic Tumor Models
Gut microbiota plays a key role in modulating responses to cancer immunotherapy in melanoma patients. Oncolytic viruses (OVs) represent emerging tools in cancer therapy, inducing a potent immunogenic cancer cell death (ICD) and recruiting immune cells in tumors, poorly infiltrated by T cells. We investigated whether the antitumoral activity of oncolytic adenovirus Ad5D24-CpG (Ad-CpG) was gut microbiota-mediated in a syngeneic mouse model of melanoma and observed that ICD was weakened by vancomycin-mediated perturbation of gut microbiota. Ad-CpG efficacy was increased by oral supplementation with Bifidobacterium, reducing melanoma progression and tumor-infiltrating regulatory T cells. Fecal microbiota was enriched in bacterial species belonging to the Firmicutes phylum in mice treated with both Bifidobacterium and Ad-CpG; furthermore, our data suggest that molecular mimicry between melanoma and Bifidobacterium-derived epitopes may favor activation of cross-reactive T cells and constitutes one of the mechanisms by which gut microbiota modulates OVs response.
38
DADA2: High-resolution sample inference from Illumina amplicon data
Benjamin J. Callahan, Paul J. McMurdie, Michael Rosen et al. · Nature Methods · 2016 · 36.3K citations
Human gut microbes associated with obesity
Ruth E. Ley, Peter J. Turnbaugh, Samuel Klein et al. · Nature · 2006 · 8.8K citations